S. 2531

119 S2531 IS: Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
 U.S. Senate
 2025-07-30
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 II  119th CONGRESS  1st Session  S. 2531  IN THE SENATE OF THE UNITED STATES   July 30, 2025   Ms. Alsobrooks  (for herself and  Ms. Lummis ) introduced the following bill; which was read twice and referred to the  Committee on Health, Education, Labor, and Pensions    A BILL
To authorize the Secretary of Health and Human Services to award grants to increase early detection of and intervention for uterine fibroids, and for other purposes.
1.
Short title
This Act may be cited as the   Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025  .
2.
Research on uterine fibroid early detection and intervention
(a)
In general
The Secretary of Health and Human Services (referred to in this Act as the  Secretary ) shall—
(1)
conduct or support research on increasing early detection of, and intervention for, uterine fibroids; and
(2)
based on the results of such research and other relevant information, formulate evidence-based or evidence-informed strategies to increase early detection in health care settings.
(b)
Timeline
The Secretary shall finalize the evidence-based or evidence-informed strategies required by subsection (a)(2) as expeditiously as possible in order to make such strategies available to grantees under section 3 to implement such strategies pursuant to section 3(b)(3).
3.
Grants with respect to uterine fibroid early detection and intervention
(a)
In general
The Secretary may award grants to States for carrying out programs—
(1)
to increase early detection of, and intervention for, uterine fibroids; and
(2)
to develop and implement public awareness and education campaigns for the early detection of, and intervention for, uterine fibroids.
(b)
Use of funds
A State receiving a grant under this section may use the grant for the following activities, with respect to increasing early detection of, and intervention for, uterine fibroids:
(1)
Screening procedures, including advanced gynecological imaging, including payment for such procedures.
(2)
Patient navigation services.
(3)
Implementation of evidence-based or evidence-informed strategies formulated under section 2(a)(2).
(4)
Facilitating access to health care settings.
4.
Research with respect to uterine fibroid early detection and intervention
The Secretary may award grants to States for the purpose of conducting research, which may include clinical trials, related to—
(1)
disparities in pain control and management in uterine fibroid surgical treatment; or
(2)
Asherman’s Syndrome, intrauterine adhesions, and other intrauterine conditions, as the Secretary determines appropriate.
5.
Reports to Congress
(a)
Reports on grants
Not later 2 years after the initial award of grants under section 2 or 3, and every 2 years thereafter, the Secretary shall submit to Congress, and make publicly available on the website of the Department of Health and Human Services—
(1)
a report summarizing the findings and results of programs and activities funded through grants awarded under this Act; and
(2)
a report outlining research developments and findings related to—
(A)
disparities in pain control and management in uterine fibroid surgical treatment; and
(B)
Asherman’s Syndrome, intrauterine adhesions, and other intrauterine conditions, as the Secretary determines appropriate.